AB

Avinash Babasaheb Andhale

Active Director Designated Partner DIN 10761948
DIN 10761948 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Avinash Babasaheb Andhale

Data last updated:

Avinash Babasaheb Andhale is a Designated Partner at Medlex360 Llp (since 2024).

DIN 10761948
Primary Designation Designated Partner
First Appointment 30 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medlex360 Llp ACJ-2410
Designated Partner30 Aug 20242024Active

Board colleagues of Avinash Babasaheb Andhale

NameDINCompanyDesignation
Deepak Dilip Datar10761947Medlex360 LlpDesignated Partner
Nitin Shrikant Tabib10658255Medlex360 LlpDesignated Partner
Philemon Kurian Cherian10761949Medlex360 LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Medlex360 Llp
Premium access

Shareholding and investment profile for Avinash Babasaheb Andhale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Babasaheb Andhale

Avinash Babasaheb Andhale currently holds 1 directorship: Medlex360 Llp (Designated Partner, since 30 Aug 2024).

Avinash Babasaheb Andhale was first appointed on 30 Aug 2024 as Designated Partner at Medlex360 Llp.

The current boards of Avinash Babasaheb Andhale's companies include Deepak Dilip Datar (Medlex360 Llp), Nitin Shrikant Tabib (Medlex360 Llp), Philemon Kurian Cherian (Medlex360 Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available